TAILIEUCHUNG - Innovations in Supporting Local Health Systems for Global Women’s Health

Conventional approaches to health in poor countries focus on disease–specific interventions and their cost effectiveness, implemented via the path of least resistance with a strong emphasis on short term results. The upshot is that sys- temic problems which underlie poor health, failing health systems, and health inequity are circumvented. Long–term, sustainable strategies are rarely devel- oped or deployed. The crisis may change its spots, expressing itself in different diseases, populations or geographic areas, but it essentially continues unabated. The most fundamental challenge is to sustain the political pressure and leadership required over the long term to strengthen and restore health systems — health systems that will not. | InnovaSon itfn SuppoZtingivT Local Health Systems for Global Women s Health Summary Report of the Wye River MD Conference Hosted by Realizing Rights The Ethical Globalization Initiative Council of Women World Leaders Columbia University Mailman School of Public Health Sponsors Realizing Rights The Ethical Globalization Initiative EGI is a project led by former President of Ireland and United Nations High Commissioner for Human Rights Mary Robinson and is a partnership of the Aspen Institute Columbia University and the International Council on Human Rights Policy. EGI s mission is to mobilize and influence political economic and civil society leaders in order to tackle global inequities by connecting human security human development and human rights. The Council of Women World Leaders is a network of current and former prime ministers presidents and cabinet ministers whose mission is to mobilize the highest-level women leaders globally for collective action on issues of critical importance to women and equitable development. Through its networks summits and partnerships the Council promotes good governance and gender equality and enhances the experience of democracy globally by increasing the number effectiveness and visibility of women who lead their countries. Columbia University Mailman School of Public Health is the only accredited school of public health in New York City and is among the first in the nation. Its students and multidisciplinary faculty members engage in research both locally and globally concentrating on biostatistics environmental health sciences epidemiology health policy and management population and family health and sociomedical sciences. In the field of global health the Mailman School has played a leadership role in improving delivery of health services through such programs as its Averting Maternal Death and Disability AMDD program its MTCT-Plus Initiative and other AIDS programs and through its involvement in the UN Millennium Project .

• Sức khỏe phụ nữ
• Systemic Therapy
• Advanced Pancreatic Carcinoma
• Immunotherapy
• Overview
• Bacterial Immunotherapy
• Antitumoral Potential
• Hepatocellular carcinoma
• Systemic therapy for hepatocellular carcinoma
• Adjuvant regimens for HCC
• Sorafenib was first approved
• Prolong survival of the patients
• Barcelona Classification
• Summary of doctoral thesis
• Immune disorders and results of pulse methylprednisolone therapy
• Severe systemic lupus erythematosus
• Target organ damage and activity level
• Pulsed methylprednisolone therapy combined
• BMC Cancer
• Adjuvant temozolomide
• Multimodality therapy approaches
• Systemic treatment
• Radiation therapy
• BMC Pulmonary medicine
• Systemic glucocorticoid therapy
• Plasma metabolome
• Systemic glucocorticoid
• Acute exacerbation
• Chronic obstructive pulmonary disease
• Phase II trial
• Selective internal radiation therapy
• Systemic chemotherapy
• Liver predominant metastases
• Pancreatic adenocarcinoma
• Bladder cancer
• Radical cystectomy
• Perioperative chemotherapy
• Perioperative targeted therapy
• Immune therapy
• Gene therapy
• Human HCC cells
• Modified molecule
• Systemic HCC therapy
• Ewing sarcoma
• Complete remission
• Metastatic disease
• Distant metastasis
• Biliary cancer
• Younger patients
• Prospective trials
• Corticosteroids and steroid therapy
• Steroid therapy
• The manager
• Chronic subdural hematoma
• Clinical considerations
• Systemic autoimmune diseases
• Risk factors
• Intrauterine therapy
• Hormonal therapy
• Metritis in cattle
• Competitive mortality
• Non tumoral death
• Head and neck cancer
• Breast cancer
• Neoadjuvant systemic therapy
• Nodal staging
• Chest CT
• BMC Musculoskeletal Disorders
• Rheumatoid arthritis
• Systemic lupus erythematosus
• Autoimmune disorders
• Osteoporotic fractures
• BMC Anesthesiology
• Local anesthetic systemic toxicity
• Lipid rescue therapy
• Intravenous lipid emulsions
• Several international anesthesia organizations
• Carbon monoxide
• Life threatening
• Systemic hyperbaric oxygen
• CO detoxification
• Severely intoxicated patients
• Prognostic models
• Review and critical appraisal
• Advanced hepatocellular carcinoma
• Liver cancer
• Randomized controlled trial
• Systemic anticancer therapy
• Targeted therapy
• Non standard
• Survival outcomes
• Slow growing neoplasm
• Radiological response
• Pancreatic cancer
• Advanced disease
• Second line therapy Progression free survival
• Overall survival
• Biliary tract cancer
• Combination therapy
• Prior systemic therapies
• Prospective randomized
• Neoadjuvant treatment
• Endocrine therapy
• Treatment response
• Post treatment surgical management